Huntsman Cancer Institute Becomes the First Mediso Preclinical Imaging Center of Excellence in North America
Salt Lake City, Utah and Boston, MA, September 21, 2015 /PRNewswire/ The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI), part of the University of Utah Health Care system in Salt Lake City, UT, has become the first site in North America to be designated as a Center of Excellence for Preclinical Imaging by Mediso Ltd. and its affiliate company Mediso USA.
Tübingen, Germany, 23 February, 2015: University of Tübingen and Mediso enters into a collaboration to develop a preclinical PET insert for simultaneous acquisition in high field MRI systems
GÖTEBORG, Sweden, October 20, 2014: Mediso Ltd announced today at the annual congress of the European Association of Nuclear Medicine the launch of new MRI subsystems with 3 and 7 Tesla field strength. This cryogen-free based technology is to be integrated into the nanoScan pre-clinical multimodality imaging platform.
GOTHENBURG, Sweden, October 17, 2014: Mediso announces the MultiScan LFER 150 PET/CT, the first member of the MultiScan product line dedicated to research applications for both clinical and pre-clinical imaging. The LFER 150 (Large Field of view Extreme Resolution) with 20 cm axial and 15 cm transaxial field of view (FOV), sub-mm PET resolution and 5% sensitivity is aimed at pre-clinical brain research.
Mediso Industry Workshop at WMIC 2014 'State-of-the-art multimodal molecular PET, SPECT, CT and MR imaging'
Please join us for our Industry Workshop at WMIC 2014 on Thursday, September 18 from 07:30am.
Mediso as co-developer and sole manufacturer is committed to providing comprehensive lifetime support for NanoSPECT/CT® and NanoPET/CT® pre-clinical imagers around the world.